YSBPW logo

YS Biopharma Co., Ltd. Warrants


YSBPW: YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.


Show YSBPW Financials

Consumer Interest
SEC Filings

Recent trades of YSBPW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by YSBPW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of YSBPW in WallStreetBets Daily Discussion


Recent insights relating to YSBPW

CNBC Recommendations

Recent picks made for YSBPW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in YSBPW

Corporate Flights

Flights by private jets registered to YSBPW